Anti-cancer activity and mechanisms of 25-anhydrocimigenol-3-O-β-D- xylopyranoside isolated from Souliea vaginata on hepatomas

Anti-Cancer Drugs

Volumn 17, Issue 5, 2006, Pages 545-551

  Tian, Ze ^a,b   Zhou, Liang ^a   Huang, Feng ^a,c   Chen, Sibao ^a,c   Yang, Junshan ^a   Wu, Erxi ^d   Xiao, Peigen ^a   Yang, Mengsu ^b  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

25 anhydrocimigenol 3 O D xylopyranoside; Anti proliferation; Apoptosis; Cell cycle; Implanted mice hepatoma

Indexed keywords

25 ANHYDROCIMIGENOL 3 O BETA DEXTRO XYLOPYRANOSIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRUCTURE; CLONOGENESIS; CLONOGENIC ASSAY; COLORIMETRY; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG MECHANISM; FLOW CYTOMETRY; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RANUNCULACEAE; RECEPTOR UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; RANUNCULACEAE; RAS PROTEINS; TRITERPENES; UP-REGULATION;

EID: 33748170693     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1002/macp.200500462     Document Type: Article

References (34)

1. Institute of Botany, Chinese Academy of Sciences and Institute of Materia Medica, Chinese Academy of Medical Sciences. Flora Republicae Popularis Sinicae 27. Beijing: Science Press; 1979. pp. 91-93.
2. Zhou L, Yang JS, Zou JH, Tu GZ. Three new cycloartane triterpene glycosides from Souliea vaginata. Chem Pharm Bull (Tokyo) 2004; 52:622-624.
3. Zhou L, Yang JS, Wu X, Zou JH, Xu XD, Tu GZ. Two new cycloartane triterpene glycosides and a new alkaloid from Souliea vaginata. Heterocycles 2005; 65:1409-1414.
4. Zhou L, Yang JS, Tu GZ. A new cycloartane triterpene glycoside from Souliea vaginata. Chin Chem Lett 2005; 16:1047-1049.
5. Pan RL, Chen DH, Si JY, Zhao XH, Shen LG. Studies on the triterpenoid constituents from the aerial part of Cimicifuga foetida. Acta Pharm Sinica 2002; 37:117-120.
6. Liu Y, Chen DH, Si JY, Pan RL, Tu GZ, An DG. Two new cyclolanstanol xylosides from the aerial parts of Cimicifuga dahurica. J Nat Prod 2002; 65:1486-1488.
7. Kusano G. Studies on the constituents of Cimicifuga species. Yakugaku Zasshi 2001; 121:497-521.
8. Watanabe K, Mimaki Y, Sakagami H, Sashida Y. Cycloartane glycosides from the rhizomes of Cimicifuga racemosa and their cytotoxic activities. Chem Pharm Bull 2002; 50:121-125.
9. Einbond LS, Shimizu M, Xiao D, Nuntanakorn P, Lim JT, Suzui M, et al. Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells. Breast Cancer Res Treat 2004; 83:221-231.
10. Tian Z, Yang MS, Huang F, Li KG, Shi L, Chen SB, et al. Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica. Cancer Lett 2005; 226:65-75.
11. Tian Z, Pan RL, Si JY, Xiao PG. Cytotoxicity of cycloartane triterpenoids from aerial part of Cimicifuga foetida. Fitoterapia 2006; 77:39-42.
12. Kadota S, Li JX, Tanaka K, Namba T. Constituents of Cimicifugae rhizome. Isolation and structures of new cycloartenol triterpenoids and related compounds from Cimicifuga foetida L. Tetrahedron 1995; 51:1143-1166.
13. Carmichael J, DeGraff WC, Gazdar AF, Minna JB, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity. Cancer Res 1987; 47:936-942.
14. CIP1 and inhibition of expression of cyclin D11. Cancer Res 2002; 62:3997-4006.
15. Shimizu M, Suzui M, Deguch A, Lim JT, Xiao D, Hayes JH, et al. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells. Clin Cancer Res 2004; 10:6710-6721.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
17. Towbin H, Staehelin T, Gordon J, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76:4350-4354.
18. Kumara SS, Hauat BT. Extraction, isolation and characterization of antitumor principle, α-hederin, from the seeds of Nigella sativa. Planta Med 2001; 67:29-32.
19. Yeh CT, Yen GC. Induction of apoptosis by the anthocyanidins through regulation of Bcl-2 gene and activation of c-Jun N-terminal kinase cascade in hepatoma cells. J Agric Food Chem 2005; 53:1740-1749.
20. 2/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells. Biochem Pharmacol 2001; 62:1439-1447.
21. Kessel D, Luo Y. Cells in cryptophycin-induced cell-cycle arrest are susceptible to apoptosis. Cancer Lett 2000; 151:25-29.
22. Fujimoto K, Hosotani R, Doi R, Wada M, Lee JU, Koshiba T, et al. Induction of cell cycle arrest and apoptosis by a novel retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer cells. Int J Cancer 1999; 81:637-644.
23. Tong X, Lin S, Fujii M, Hou DX. Molecular mechanisms of echinocystic acid-induced apoptosis in HepG2 cells. Biochem Biophys Res Commun 2004; 321:539-546.
24. Oh SH, Lee BH. A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage. Toxicol Appl Pharmacol 2004; 194:221-229.
25. L ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sci 2005; 76:1883-1893.
26. Ocker M, Herold C, Ganslmayer M, Zopf S, Hahn EG, Schuppan D. Potentiated anticancer effects on hepatoma cells by the retinoid adapalene. Cancer Lett 2004; 208:51-58.
27. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281:1312-1316.
28. 1 arrest followed by necrotic cell death. Cancer Res. 1999; 59:3565-3569.
29. Zhang MC, Liu HP, Demchik LL, Zhai YF, Yang da J. Light sensitizes IFN-gamma-mediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways. Cell Res 2004; 14:117-124.
30. Buecher B, Broquet A, Bouancheau D, Heymann MF, Jany A, Denis MG, et al. Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines. Dig Liver Dis 2003; 35:557-565.
31. 2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998; 18:629-643.
32. Nakanishi M, Kagawa Y, Takahashi H, Matsushime H. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex. Leukemia 1997; 11(Suppl):356-357.
33. Waf1/Cip1 protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J 2003; 22:2036-2046.
34. WAF1/CIP1 regulates the p300 HSumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK binding. Cell Cycle 2005; 4:1113-1119.